Related Experiment Videos
Persistent akathisia associated with early tardive dyskinesia
Postgraduate Medical Journal
|May 1, 1984
Summary
Persistent akathisia may signal early tardive dyskinesia in psychiatric patients. This movement disorder can emerge young, within a year of starting antipsychotic medications, even at reduced doses.
Area of Science:
- Psychiatry
- Neuroscience
- Pharmacology
Background:
- Antipsychotic medications are crucial for managing psychiatric disorders.
- Tardive dyskinesia (TD) is a potential side effect of long-term antipsychotic use.
- Akathisia is a common, often distressing, side effect characterized by a feeling of inner restlessness.
Observation:
- Two young psychiatric patients developed moderate to severe oro-facial and limb dyskinesia.
- These movement disorders appeared within one year of initiating antipsychotic drug treatment.
- Both patients experienced persistent akathisia early in treatment, which continued despite dose reductions.
Findings:
- The early onset of tardive dyskinesia was observed in these patients.
- Persistent akathisia preceded the development of tardive dyskinesia.
- The emergence of TD occurred despite maintenance-level doses of antipsychotic medication.
Implications:
- Persistent akathisia may serve as an early warning sign for the development of tardive dyskinesia.
- Clinicians should be vigilant for akathisia in patients on antipsychotics, especially younger individuals.
- Early recognition and management of akathisia could potentially mitigate the risk or severity of tardive dyskinesia.